The Latest Headlines at The Cerbat Gem


Analyzing eGain (NASDAQ:EGAN) & Zenvia (NASDAQ:ZENV)
eGain (NASDAQ:EGAN – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of... More of this article »
Head to Head Analysis: SI-BONE (NASDAQ:SIBN) & Invo Bioscience (OTCMKTS:IVOB)
SI-BONE (NASDAQ:SIBN – Get Rating) and Invo Bioscience (OTCMKTS:IVOB – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends,... More of this article »
Close Brothers Group plc (LON:CBG) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Close Brothers Group plc (LON:CBG – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment... More of this article »
Synovus Financial (NYSE:SNV) PT Lowered to $35.00 at Truist Financial
Synovus Financial (NYSE:SNV – Get Rating) had its price objective decreased by Truist Financial from $48.00 to $35.00 in a research report released on Thursday, The Fly reports. A number of other equities analysts also recently... More of this article »
Allstate (NYSE:ALL) PT Lowered to $132.00 at Evercore ISI
Allstate (NYSE:ALL – Get Rating) had its target price cut by Evercore ISI from $138.00 to $132.00 in a research note published on Thursday, The Fly reports. They currently have an in-line rating on the insurance provider’s... More of this article »
GigaCloud Technology (GCT) versus Its Competitors Financial Comparison
GigaCloud Technology (NASDAQ:GCT – Get Rating) is one of 54 publicly-traded companies in the “Catalog & mail – order houses” industry, but how does it contrast to its peers? We will compare GigaCloud Technology... More of this article »
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $862.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Rating) had its price objective hoisted by EF Hutton Acquisition Co. I from $853.00 to $862.00 in a report issued on Thursday, Benzinga reports. They currently have a buy rating on... More of this article »
Live Oak Bancshares (NASDAQ:LOB) PT Lowered to $29.00 at Truist Financial
Live Oak Bancshares (NASDAQ:LOB – Get Rating) had its price target decreased by Truist Financial from $37.00 to $29.00 in a research report report published on Thursday, The Fly reports. Truist Financial currently has a buy rating... More of this article »
HC Wainwright Trims Werewolf Therapeutics (NASDAQ:HOWL) Target Price to $15.00
Werewolf Therapeutics (NASDAQ:HOWL – Get Rating) had its target price reduced by HC Wainwright from $20.00 to $15.00 in a research note released on Thursday morning, The Fly reports. They currently have a buy rating on the stock. Separately,... More of this article »
Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Rating) have been given an average rating of “Hold” by the eight ratings firms that are covering the stock, MarketBeat Ratings reports. Three investment analysts have... More of this article »
Almaden Minerals (NYSEAMERICAN:AAU) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU – Get Rating) (TSE:AMM) in a research report sent to investors on Thursday. The brokerage issued a sell rating on the basic materials company’s... More of this article »
StockNews.com Upgrades Ryder System (NYSE:R) to Strong-Buy
StockNews.com upgraded shares of Ryder System (NYSE:R – Get Rating) from a buy rating to a strong-buy rating in a research note published on Thursday. Other research analysts have also issued reports about the stock. Wolfe Research... More of this article »
Check-Cap (NASDAQ:CHEK) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the medical research company’s stock. Check-Cap Trading... More of this article »